ClinicalTrials.Veeva

Menu

Clinical Determinants of the 6 Minute Walk Test in Cerebral Palsy

G

Gazi University

Status

Unknown

Conditions

Cerebral Palsy
Exercise

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Cerebral Palsy (CP) is a group of permanent disorders of movement and posture, generally accompanied by secondary musculoskeletal problems. Studies in literature showed taht children with CP supports a link between the levels of impairment and walking ability. The 6 Minute walk test is a standardized, self-placed walking test commonly used to access functional ability in children with cerebral palsy. While decreased exercise capacity has been identified in children with cerebral palsy, the clinical determinants of the 6MWT in this population have not been investigated yet. Thus the aim of this study is to investigate the relationship between 6 Minute walk test, quality of life, respiratory muscle strength,activities of daily living using with Pediatric Evaluation of Disability Inventory and trunk control.

Full description

A convenience of children with hemiparetic and diplegia CP, 7-14 years, is going to recruited from Gazi University, Faculty of Health Science, Department of Physiotherapy and Rehabilitation. Every each of patients respiratory muscle strength will be evaluated using with electronic mouth pressure device, trunk control with using trunk control measurement scale, activities of daily living using with Pediatric Evaluation of Disability Inventory (PEDI), functional exercise capacity usin with six minute walk test (6MWT) and quality of life using with Cerebral Palsy Quality of Life Questionnaire (CPQOL).

Enrollment

25 estimated patients

Sex

All

Ages

7 to 14 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Aged 7-14 years
  • Diagnosed to spastic cerebral palsy
  • Gross Motor Function Classification System levels I or II.
  • Have no earlier interventions in the form of orthopaedic surgery or injection with botulinum toxin type A in the 6 month prior to baseline assessments
  • Child are able to demonstrate sufficient co-operation and cognitive understanding participating

Exclusion criteria

  • Active medical condition impairment (pneumonia etc.)
  • Do not accommodate the study
  • Do not want to attempt the study

Trial design

25 participants in 1 patient group

Children with cerebral palsy
Description:
Children with cerebral palsy, who can walking dependently and continuously for 6 minutes.

Trial contacts and locations

2

Loading...

Central trial contact

Muserref KELES, Msc

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems